(Q61908019)

English

Rifaximin-Extended Intestinal Release Induces Remission in Patients With Moderately Active Crohn's Disease

scientific article published in March 2012

Statements

Rifaximin-extended intestinal release induces remission in patients with moderately active Crohn's disease (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit